Abstract:G protein-coupled receptors (GPCRs) mediate different cell transmembrane signal transduction, and are important drug targets. The beta-arrestin mediated pathway is one of the important ways for GPCRs to play their function, which owns important significance for regulation of the function of GPCRs. However, until now it is still not clear how beta-arrestin interacts with GPCRs and mediates their trans-membraned signal transduction pathway. To address this issue,the CC chemokine receptor 3 (CCR3) was selected to study the interaction between beta-arrestin and GPCRs. Firstly, a co-expression system of beta-arrestin and CCR3 was constructed, and the interaction between beta-arrestin and CCR3 in living cells was analyzed using laser confocal fluorescence microscopy and fluorescence resonance energy transfer techniques. And the regulation effect of beta-arrestin on the chemotaxis of CCR3 stably transfected cells was also studied by RNAi and chemotaxis experiments. In addition, the interaction between beta-arrestin mutant (R169E) and CCR3 was further confirmed using QCM technology in vitro, and their binding constant was also determined. As a result, upon the stimulation of CCL11 (chemokine C-C motif ligand 11), the intracellular distance between beta-arrestin and CCR3 was significantly changed, and beta-arrestin protein was recruited to the cell membrane, which suggests that beta-arrestin could interact with CCR3 and involve in the CCR3-mediated signal transduction process. After silencing beta-arrestin by transfection with beta-arrestin-siRNA, the migration of CCR3 stablely transfected cells induced by CCL11 and CCL24 was significantly decreased, while the migration rate induced by CCL5 was not obviously changed. These results indicated that different chemokines shows different regulatory effects on the interaction between CCR3 and beta-arrestin. In vitro binding experiments further confirmed the interaction between beta-arrestin and CCR3, and the binding constant K-D between beta-arrestin mutant and CCR3 was determined as 1.35 x 10(-7). In conclusion, beta-arrestin can interact with CCR3 in living cells, and plays an important role in CCR3-mediated cell transmembrane signal transduction.

Β-Arrestin2 is Critically Involved in CXCR4-mediated Chemotaxis, and This is Mediated by Its Enhancement of P38 MAPK Activation

Beta-Arrestin Differentially Regulates The Chemokine Receptor Cxcr4-Mediated Signaling And Receptor Internalization, And This Implicates Multiple Interaction Sites Between Beta-Arrestin And Cxcr4

β-Arrestin1 and β-Arrestin2 Are Required to Support the Activity of the CXCL12/HMGB1 Heterocomplex on CXCR4

Study On Interaction Of Human Chemokine Receptor Ccr3 And Beta-Arrestin

Β-Arrestin 2 Negatively Regulates Toll-like Receptor 4 (Tlr4)-Triggered Inflammatory Signaling Via Targeting P38 MAPK and Interleukin 10.

Differential Effects of Beta-Arrestins on the Internalization, Desensitization and Erk1/2 Activation Downstream of Protease Activated Receptor-2

Altered CXCR2 signaling in beta-arrestin-2-deficient mouse models.

Β-Arrestin2 Recruitment by Β-Adrenergic Receptor Agonists and Antagonists

Β-Arrestin2 Mediates Β-2 Adrenergic Receptor Signaling Inducing Prostate Cancer Cell Progression

β-Arrestin 1-dependent regulation of Rap2 is required for fMLP-stimulated chemotaxis in neutrophil-like HL-60 cells

β-Arrestin-1-dependent activation of extracellular signal-regulated kinases in RON receptor-mediated tumorigenic activities in colon cancer cells

The role and mechanism of β-arrestin2 in signal transduction

Genetic Evidence That Β-Arrestins Are Dispensable for the Initiation of Β2-Adrenergic Receptor Signaling to ERK

A Novel Protein Kinase A-independent, Β-Arrestin-1-dependent Signaling Pathway for P38 Mitogen-activated Protein Kinase Activation by Β2-Adrenergic Receptors

The Human Chemokine Receptor CCRL2 Suppresses Chemotaxis and Invasion by Blocking CCL2-induced Phosphorylation of P38 MAPK in Human Breast Cancer Cells

Altered CXCR2 Signaling in β-Arrestin-2-Deficient Mouse Models

G protein–coupled receptor kinase phosphorylation of distal C-tail sites specifies βarrestin1-mediated signaling by chemokine receptor CXCR4

p38 MAPK and ERK activation by 9-cis-retinoic acid induces chemokine receptors CCR1 and CCR2 expression in human monocytic THP-1 cells

Beta-Arrestin 2 Functions As A G-Protein-Coupled Receptor-Activated Regulator Of Oncoprotein Mdm2

β-arrestin 2 regulates Toll-like receptor 4-mediated apoptotic signalling through glycogen synthase kinase-3β.

β-Arrestin 2 regulates toll-like receptor 4-mediated apoptotic signalling through glycogen synthase kinase-3β: β-arrestin 2 regulates TLR4-mediated apoptosis